Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Peripheral Arterial Disease”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Testing effectiveness (Phase 2)Study completedNCT00616980
What this trial is testing

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia

Who this might be right for
Peripheral Artery DiseasePeripheral Vascular DiseaseCritical Limb Ischemia
Losordo, Douglas, M.D. 28
Not applicableStudy completedNCT01804088
What this trial is testing

FORMAT Clinical Study

Who this might be right for
Symptomatic Vascular Disease of the Iliac Arteries
Cook Group Incorporated 80
Not applicableStudy completedNCT02400905
What this trial is testing

Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

Who this might be right for
Peripheral Arterial Disease
Veryan Medical Ltd. 271
Not applicableStudy completedNCT03847233
What this trial is testing

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)

Who this might be right for
Peripheral Arterial Disease
Boston Scientific Corporation 31
Not applicableUnknownNCT00538408
What this trial is testing

Whole Body Magnetic Resonance Angiography in Ischemic Patients

Who this might be right for
AtherosclerosisIntermittent Claudication
Copenhagen University Hospital at Herlev 80
Large-scale testing (Phase 3)UnknownNCT04229264
What this trial is testing

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Who this might be right for
Critical Limb Ischemia
Science Valley Research Institute 200
Not applicableUnknownNCT06047002
What this trial is testing

Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
University of Leicester 150
Not applicableStudy completedNCT03098290
What this trial is testing

IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)

Who this might be right for
Symptomatic Peripheral Arterial DiseaseOcclusive Disease of Artery of Lower ExtremityQuality of Life
Universitätsklinikum Hamburg-Eppendorf 5,608
Not applicableStudy completedNCT04298567
What this trial is testing

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Who this might be right for
Prevention of Atherothrombotic EventsCoronary Artery Disease (CAD)Symptomatic Peripheral Artery Disease (Symptomatic PAD)
Bayer 300
Not applicableStudy completedNCT02701543
What this trial is testing

Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease

Who this might be right for
Peripheral Artery Disease
University of Leipzig 414
Not applicableStudy completedNCT06234280
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Not applicableUnknownNCT04305028
What this trial is testing

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Who this might be right for
Peripheral Arterial Disease
Poznan University of Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT04040322
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 198
Not applicableStudy completedNCT03693053
What this trial is testing

Socioeconomic Deprivation and Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
University Hospital, Grenoble 150
Not applicableLooking for participantsNCT05612945
What this trial is testing

High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD

Who this might be right for
Peripheral Arterial Disease
Centre Hospitalier Universitaire Vaudois 60
Testing effectiveness (Phase 2)Study completedNCT00403494
What this trial is testing

The Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease

Who this might be right for
Intermittent Claudication
BioMarin Pharmaceutical 190
Post-approval studies (Phase 4)Looking for participantsNCT07112183
What this trial is testing

Open Label Treprostinil Raynaud's Study

Who this might be right for
Raynaud's DiseaseRaynaud PhenomenaRaynauds
Brigham and Women's Hospital 30
Not applicableLooking for participantsNCT06369402
What this trial is testing

Cognitive Impairment and Cerebral Haemodynamics in Individuals With Symptomatic Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial DiseaseCognitive Impairment
University of Leicester 40
Not applicableStudy completedNCT03435835
What this trial is testing

Heat Therapy to Reduce Pain and Improve Walking Tolerance

Who this might be right for
Peripheral Arterial Disease
Indiana University 19
Post-approval studies (Phase 4)Study completedNCT00906022
What this trial is testing

Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)

Who this might be right for
Patients With Symptomatic Critical Limb IschemiaSevere Intermittent Claudication
Biotronik AG 94
Load More Results